Skip to main content

Table 2 24-h CGM data of each HbA1c group

From: The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes

HbA1c

Group A

HbA1c ≤7.2 %

Group B

7.2 % <HbA1c ≤8.2 %

Group C

Group D

HbA1c >9.2 %

P value

8.2 % <HbA1c ≤9.2 %

Mean glucose levels (mg/dL)a

133.0

(113.5‒154.8)

157.5

(131.5‒187.5)

182.0

(152.0‒206.0)

186.0

(143.0‒214.8)

<0.001

SDa

53.0

(40.0‒65.0)

53.5

(44.8‒69.8)

64.0

(55.0‒76.0)

58.0

(48.0‒80.0)

0.165

MAGE (mg/dL)a

99.3

(62.4–149.0)

99.7

(78.5–130.3)

103.3

(81.8–127.9)

89.8

(66.7–119.6)

0.783

%CV a

40.7

(32.8–51.2)

34.0

(30.8–45.1)

37.6

(30.1–41.0)

36.8

(27.1–45.6)

0.405

J-index a

38.7

(24.8–44.1)

51.0

(31.5–61.5)

64.7

(44.1–82.6)

65.2

(40.5–82.8)

<0.001

M value a

10.9

(6.7–20.2)

15.1

(7.6–18.3)

17.5

(10.3–29.9)

19.4

(9.6–27.4)

0.126

MODD (mg/dL)a

43.9

(31.3–54.4)

53.5

(41.8–64.1)

53.5

(39.7–89.6)

57.7

(41.0–81.4)

0.163

Time in hypoglycemia (min)a

170.0

(57.5‒341.3)

77.5

(0‒210.0)

45.0

(0‒105.0)

20.0

(0‒105.0)

0.014

Time in nocturnal hypoglycemia (min)a

120.0

(5.0‒268.8)

25.0

(0‒120.0)

0

(0‒60.0)

0

(0‒88.8)

0.019

LBGI a

5.7

(2.6–9.0)

3.6

(0.9–6.8)

3.9

(1.2–10.8)

2.2

(0.6–5.6)

0.162

Time in hyperglycemia (min)a

335.0

(147.5‒446.3)

457.5

(193.8‒722.5)

715.0

(425.0‒945.0)

675.0

(351.3‒953.8)

0.001

HBGI a

8.1

(5.4–9.3)

10.9

(6.0–13.8)

13.2

(8.4–19.4)

13.7

(6.6–20.4)

0.003

  1. Data presented as median (25–75 percentiles)
  2. Italic values indicate significance of P value (P < 0.05)
  3. aKruskal–Wallis test